SCHEMBL14476609

SCHEMBL14476609

CCOC(=O)C1=C(NCc2nccn2Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)CCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HSP90AA1 P07900 2/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ NR3C1 P04150 2/20 0.39
▸ FPR2 P25090 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TRPM2 O94759 1/20 0.37
▸ CCR1 P32246 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SLC34A1 Q06495 1/20 0.36
▸ TLR2 O60603 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ OPRD1 P41143 2/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ SSTR5 P35346 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14476743 0.86 MAPT (0.39) MEN1KMT2AKDM4EMAPTHSP90AA1
SCHEMBL15692202 0.81 MAPT (0.40) MEN1KMT2AKDM4EMAPTHSP90AA1
SCHEMBL17629541 0.79 KCNQ2 (0.48) MEN1KMT2AKDM4EMAPTHSP90AA1
SCHEMBL14477124 0.77 PLA2G7 (0.39) MEN1KMT2AKDM4EMAPTHSP90AA1
SCHEMBL15804431 0.74 CCR1 (0.39) KDM4EALDH1A1CCR1
SCHEMBL15807091 0.73 MAPT (0.38) MEN1KMT2AKDM4EMAPTHSP90AA1
SCHEMBL15654157 0.70 ROCK2 (0.40) MAPTALDH1A1TRPM2HPGD
SCHEMBL14476615 0.69 ALDH1A1 (0.42) KDM4EHSP90AA1NR3C1ALDH1A1CCR1
SCHEMBL335695 0.69 NPC1 (0.50) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL4489784 0.69 MAPT (0.50) MEN1KMT2AKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140171431-A1 AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2014-06-19 — — US disclosed
US-20140171431-A1 AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2014-06-19 — — US disclosed
EP-2725024-A1 AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2014-04-30 — — EP disclosed
WO-2013000108-A1 AZOLE HETEROCYLIC COMPOUNDS, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 中国科学院上海药物研究所 (CN) 2013-01-03 — — WO disclosed
WO-2013000267-A1 AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE 中国科学院上海药物研究所 (CN) 2013-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140171431-A1 AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE PLA2G5, LTA4H, PLA2G4A MEN1 1272/4885KMT2A 2320/4885KDM4E 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback